Aldeyra Therapeutics's total assets for Q2 2025 were $84.96M, a decrease of -8.83% from the previous quarter. ALDX total liabilities were $29.67M for the fiscal quarter, a 0.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.